Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
Photo: BBC WorldThe US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION
Originally published by BBC World. Summary and curation by DutyStation News.
